RxDoctor Payments Data

Alex Anderson, DO

Family Medicine · Greenfield, OHNPI 1235662628

Payments from drug & device makers

$504in general payments, 2019–2025

Across 28 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$182
  • Novo Nordisk$90
  • Teva Pharmaceuticals USA, Inc.$34
  • Amarin Pharma, Inc.$31
  • Mylan Specialty L.p.$29
  • Intuitive Surgical$28
  • plus $110 from 6 others

What the payments were for

  • Food & beverage$504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$504 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$17,531
Medicare patients
93
Services billed
307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$68,709
JardianceEmpagliflozin63$66,699
Spiriva RespimatTiotropium Bromide66$45,908
TrulicityDulaglutide30$36,535
MounjaroTirzepatide23$33,372
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$26,047
EliquisApixaban33$23,426
FarxigaDapagliflozin Propanediol24$21,624
ArexvyRsvpref3 Antigen/As01e/Pf63$18,950
JanuviaSitagliptin Phosphate24$18,555
XareltoRivaroxaban18$16,460
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$12,386
Incruse ElliptaUmeclidinium Bromide26$11,587
Atrovent HfaIpratropium Bromide15$10,734
EntrestoSacubitril/Valsartan11$10,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arexvy, Incruse Ellipta, Breo Ellipta, Shingrix$21$69,836156 claims
Novo NordiskOzempic$90$68,70966 claims
PfizerEliquis$14$23,42633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Greenfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →